Dr. Rahul Pratap Singh obtained his Ph.D. degree in Pharmaceutics from Banaras Hindu University in 2017, after his B. Pharm. (Pharmaceutical Sciences, 2009) and M. Pharm. (Pharmaceutics, 2011) degrees, both from Bundelkhand University, Jhansi, India. Dr. Singh took the prestigious Junior and Senior Research Fellowship from University Grants Commission, New Delhi at Department of Pharmacology, Institute of Medical Sciences, Baranas Hindu University, Varanasi, India during 2013-2016. From December 2016 to September 2017, Dr. Singh worked as a Research Associate in the Formulation and Development (F&D) at Mankind Research Centre (MRC), Gurgaon. After a short period at MRC, Gurgaon as F&D Scientist, Dr. Singh joined Department of Pharmacy, School of Medical and Allied Sciences, GD Goenka University, Gurgaon, India in October 2017 as an Assistant Professor in Pharmaceutics. As Assistant Professor of Pharmaceutics has been a leading researcher in biotechnology and pharmaceutical sciences. His expertise embraces the development of multifunctional targeted theranostic nanomedicine to deliver therapeutic and diagnostic agents in cancer therapy, particularly anticancer drugs, genetically engineered proteins, and peptides continuously at controlled rates for prolonged periods of time. Dr. Singh is a recipient of BIRAC-SRISTI (Biotechnology Industry Research Assistance Council- Society for Research and Initiatives for Sustainable Technologies and Institutions), Gandhian Young Technological Innovation Award 2017. He is a registered pharmacist with Pharmacy Council of India, Uttar Pradesh, India. Also, he is a lifetime member of ‘The Association of Pharmaceutical Teachers of India”. He is an active reviewer for several journals of repute. He has also published a number of research articles in peer-reviewed journals and authored few books.

Dr. Rahul Pratap Singh Research interests include drug delivery, health science, nanoscience, cancer nanotechnology, theranostics nanomedicine, design and development of receptor targeted multifunctional theranostic nanomedicine systems to facilitate drug delivery in cancer therapy.